ストックスクリーナーアプリを入手
26.54
3.81%
-1.05
Vtv Therapeutics Inc (VTVT) 最新ニュース
iOnctura appoints Paul Sekhri as Chair of its Board of Directors - GlobeNewswire Inc.
Three parties report shared voting power over vTv Therapeutics (VTVT) shares in a passive stake amendment. - Stock Titan
A new hire gets 2,500 options to buy vTv shares at $31.44 each - Stock Titan
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - marketbeat.com
vTv Therapeutics (NASDAQ:VTVT) Raised to Hold at Zacks Research - marketbeat.com
Responsive Playbooks and the VTVT Inflection - news.stocktradersdaily.com
Lifesci Capital Upgrades vTv Therapeutics (NASDAQ:VTVT) to Strong-Buy - marketbeat.com
vTv Therapeutics (VTVT) Holds Steady at $33.40 as Shares Trade FlatDiamond Pattern - vinanet.vn
Analysts Conflicted on These Healthcare Names: Kymera Therapeutics (KYMR) and vTv Therapeutics (VTVT) - theglobeandmail.com
A type 1 diabetes drug developer plans two investor events in September - Stock Titan
vTv Therapeutics (NASDAQ:VTVT) Stock Price Passes Below 50-Day Moving AverageShould You Sell? - marketbeat.com
vTv Therapeutics Q2 2026 Earnings: Net Loss Slightly Wider Than Estimates, Shares Edge HigherPerformance Review - dars.gov.et
vTv Therapeutics Inc (NASDAQ: VTVT) Share Price, VTVT Stock News, VTVT Share Price & Updates - kalkine.ca
Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High? - qz.com
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
vTv Therapeutics Inc. (NASDAQ:VTVT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
vTv Therapeutics (VTVT) Slips 2.37% to $30.12 as Support Holds in FocusDouble Top - vinanet.vn
vTv Therapeutics (VTVT) Slips 2.37% to $30.12 as Support Holds in FocusActive ETF Flow - dars.gov.et
The Technical Signals Behind (VTVT) That Institutions Follow - Stock Traders Daily
vTv Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
HC Wainwright Lowers Earnings Estimates for vTv Therapeutics - MarketBeat
vTv Therapeutics Inc (VTVT) Reports Q2 Loss of $1.05 Per Share -- What Does a GF Score of 26/100 Indicate? - GuruFocus
vTv Therapeutics Inc (VTVT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
vTv Therapeutics (NASDAQ:VTVT) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
H.C. Wainwright Maintains VTv Therapeutics(VTVT.US) With Buy Rating, Maintains Target Price $42 - Moomoo
vTv Therapeutics Inc (VTVT) Stock News Today - TradingKey
vTv Therapeutics Inc (NASDAQ: VTVT) Share Price, VTVT Stock News, VTVT Share Price & Updates - Kalkine
vTv Therapeutics Inc expected to post a loss of $1.04 a shareEarnings Preview - TradingView
vTv Therapeutics (NASDAQ:VTVT) Posts Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat
vTv Therapeutics (VTVT) Advances Diabetes Treatment Amid High Pr - GuruFocus
VTVT Maintains Buy Rating -- Price Target Lowered to $42.00 by H - GuruFocus
vTv Therapeutics (NASDAQ:VTVT) Price Target Lowered to $42.00 at HC Wainwright - MarketBeat
VTv Therapeutics: Q2 Earnings Snapshot - marketscreener.com
VTv Therapeutics: Q2 Earnings Snapshot - aol.com
vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Yahoo! Finance Canada
VTV THERAPEUTICS, INC. : H.C. WAINWRIGHT CUTS TARGET PRICE TO $42 FROM $45 - Bitget
vTv Therapeutics (VTVT) Holds Near $34.45 as Traders Eye $36.17 ResistanceVolume Breadth - dars.gov.et
vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Yahoo Finance Singapore
VTVT Q2'26 Earnings: revenue estimate is 333.33K USD - TradingView
vTv Therapeutics (VTVT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Precision Trading with Vtv Therapeutics Inc. (VTVT) Risk Zones - Stock Traders Daily
vTv Therapeutics (VTVT) Edges Down 1% to $32.35, Holding Gains Above Key SupportMotive Wave - dars.gov.et
vTv Therapeutics (NASDAQ:VTVT) Shares Pass Above Fifty Day Moving AverageHere's What Happened - marketbeat.com
vTv Therapeutics (VTVT) Edges Down 1% to $32.35, Holding Gains Above Key SupportQuality ETF - vinanet.vn
vTv Therapeutics Inc. Revenue Breakdown – NASDAQ:VTVT - tradingview.com
vTv Therapeutics Inc (VTVT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
vTv Therapeutics (VTVT): Millennium entities disclose 6.9% ownership of Class A shares - Stock Titan
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
4.22%
大文字化:
|
ボリューム (24 時間):